SPE Capital Partners has announced the acquisition of Saham Pharma, an antibiotics manufacturer and hospital provider in Morocco, alongside Proparco as a minority investor.
SPE Capital Partners and Proparco acquire…
SPE Capital Partners has announced the acquisition of Saham Pharma, an antibiotics manufacturer and hospital provider in Morocco, alongside Proparco as a minority investor.